Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Efficacy of a Novel CCH Protocol for PD Among Prior Non-responders

NCT: NCT05108558 · COMPLETED

NCT IDNCT05108558
StatusCOMPLETED
Start Date2021-09-20
Completion2026-06-13
SponsorCharitable Union for the Research and Education of Peyronie's Disease (OTHER)
First posted
Last updated

Brief Summary

Compare key clinical outcomes between controls and men treated with a novel CCH administration protocol among men previously unresponsive to CCH administration.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑